Portfolio company
Neuroharmonics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops non-invasive ultrasound devices to modulate deep brain circuits for patients with movement disorders, depression, chronic pain, and addiction.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Brain-to-Computer Interface
This company develops ultrasound-based brain-computer interfaces to treat neurological and psychiatric conditions for patients with unmet medical needs.
Ultra Bionics
The company develops implantable ultrasound technologies to provide neuromodulation and neurological disease therapies for patients with conditions such as Parkinson's and epilepsy.
Attune Neurosciences
This company develops wearable ultrasound neurostimulation devices for patients and government agencies to treat brain disorders and improve cognitive performance.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
Inner Cosmos
This company develops a minimally invasive brain-computer interface implant to treat cognitive disorders for patients suffering from depression.
Cordance Medical
This company develops a focused ultrasound device to open the blood-brain barrier for clinicians treating patients with brain tumours and other neurological diseases.
Innovative brain-machine interfaces
Merge Labs develops ultrasound-based, non-invasive brain-machine interfaces that link biological and artificial intelligence for individuals with neurological disorders and able-bodied users.
Carthera
This company develops an ultrasound-based medical device to increase the permeability of the blood-brain barrier for patients with tumours and neurodegenerative diseases.
